SynCore Biotechnology Co Ltd (4192) — Working Capital to Net Assets Ratio
SynCore Biotechnology Co Ltd (4192) has a Working Capital to Net Assets ratio of 82.7% as of September 2025. Working capital of NT$213.31 Million (current assets of NT$228.19 Million minus current liabilities of NT$14.88 Million) is measured against net assets of NT$257.97 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See financial agility of SynCore Biotechnology Co Ltd to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
SynCore Biotechnology Co Ltd Working Capital to Net Assets (2015–2024)
This chart shows how SynCore Biotechnology Co Ltd's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2015 to 2024. As of September 2025, the ratio stands at 82.7%, reflecting working capital of NT$213.31 Million against net assets of NT$257.97 Million TWD. See SynCore Biotechnology Co Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for SynCore Biotechnology Co Ltd (2015–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for SynCore Biotechnology Co Ltd from 2015 to 2024, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 4192 company net worth.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 80.9% | NT$238.34 Million | NT$294.69 Million | NT$260.46 Million | NT$22.12 Million | ▼ -0.1 pp |
| 2023 | 81.0% | NT$289.25 Million | NT$357.14 Million | NT$310.48 Million | NT$21.23 Million | ▲ +16.1 pp |
| 2022 | 64.9% | NT$161.59 Million | NT$249.01 Million | NT$348.23 Million | NT$186.64 Million | ▼ -9.4 pp |
| 2021 | 74.3% | NT$329.19 Million | NT$442.92 Million | NT$710.71 Million | NT$381.52 Million | ▲ +4.1 pp |
| 2020 | 70.3% | NT$393.86 Million | NT$560.58 Million | NT$741.98 Million | NT$348.12 Million | ▲ +4.0 pp |
| 2019 | 66.3% | NT$405.53 Million | NT$612.03 Million | NT$538.89 Million | NT$133.36 Million | ▼ -1.9 pp |
| 2018 | 68.2% | NT$481.90 Million | NT$706.70 Million | NT$545.24 Million | NT$63.34 Million | ▲ +6.2 pp |
| 2017 | 62.0% | NT$446.62 Million | NT$720.61 Million | NT$502.05 Million | NT$55.43 Million | ▼ -10.3 pp |
| 2016 | 72.3% | NT$698.67 Million | NT$966.36 Million | NT$747.88 Million | NT$49.21 Million | ▲ +21.7 pp |
| 2015 | 50.6% | NT$426.61 Million | NT$842.81 Million | NT$471.86 Million | NT$45.24 Million | — |